To study the physiological functions of MDL1AS, its expression was modulated with double-stranded interfering RNAs (DsiRNAs), as described [29]. All DsiRNAs were synthetized by Integrated DNA Technologies (Coralville, IA, USA) at 10 nmol scale (Table 1). They were diluted in RNAse-free water to a final concentration of 100 µM. For transfection, HCT116 (150,000–250,000 cells per well), MCF7, and MDA-MB-231 (50,000–100,000 cells per well) cells were seeded in six-well plates and transfected with Lipofectamine RNAiMAX (Thermo Fisher, Waltham, MA, USA), according to manufacturer’s instructions, in serum-free medium and using DsiRNA at a concentration of 10 nM.
Sequence of the DsiRNAs used to downregulate MDL1AS expression.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.